NCT07034118View on ClinicalTrials.gov

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2028

Conditions
Esophageal Carcinoma
Interventions
RADIATION

Proton radiotherapy

Patients enrolled would receive proton radiotherapy with chemoimmunotherapy.

DRUG

Immune Checkpoint Inhibitors

Patients enrolled would receive proton radiotherapy and chemoimmunotherapy

Trial Locations (1)

Unknown

Anhui Provincial Hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV